z-logo
open-access-imgOpen Access
Eribulin for heavily pre-treated metastatic breast cancer patients
Author(s) -
Antonia Digklia,
Ioannis A. Voutsadakis
Publication year - 2015
Publication title -
world journal of experimental medicine
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2220-315X
DOI - 10.5493/wjem.v5.i3.194
Subject(s) - eribulin , medicine , metastatic breast cancer , oncology , breast cancer , adverse effect , progressive disease , cancer , chemotherapy , surgery
To discuss treatment with eribulin in clinical practice outside a clinical trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here